Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-Cov2-NP1 (AA 1-180) antibody

Reactivity: Human ELISA, WB Host: Mouse Monoclonal 4C12A6 unconjugated
Catalog No. ABIN7193674
  • Target
    SARS-Cov2-NP1
    Binding Specificity
    AA 1-180
    Reactivity
    Human
    Host
    Mouse
    Clonality
    Monoclonal
    Application
    ELISA, Western Blotting (WB)
    Purification
    purified
    Immunogen
    Purified recombinant fragment of human SARS-Cov2-N (AA: 1-180) expressed in E. coli.
    Clone
    4C12A6
    Isotype
    IgG1
  • Application Notes
    WB:1:500 - 1:2000, ELISA:1:10000,
    Restrictions
    For Research Use only
  • Buffer
    Purified antibody in PBS with 0.05 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C/-20 °C
    Storage Comment
    4°C, -20°C for long term storage
  • Target
    SARS-Cov2-NP1
    Background
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target.
    Molecular Weight
    23 kDa
    Gene ID
    43740575
You are here: